Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2025-12-25 @ 3:46 AM
NCT ID:
NCT01590602
Eligibility Criteria:
Inclusion Criteria:
* A clinical diagnosis of Juvenile-onset HD (motor onset as measured by TMS \> 5, Diagnostic Confidence level = 4, AND age of onset aged 25 or younger).
* With family history of HD or DNA testing results demonstrating the presence of the HD mutation (i.e. a CAG repeat expansion within the HD gene \>35 on larger allele).
* All participants must be able to provide consent for themselves, have a parent/guardian who can provide parental permission, or have an authorized legal representative who can provide consent.
Exclusion Criteria:
* Participants who are unable to understand the study protocol or unable to give informed consent, and have no legal representative.
* Age of onset ≥26
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01590602
Study Brief:
Protocol Section:
NCT01590602